ORL Cancer

2

Review clinical trials related to ORL Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their Partners

Single-centre prospective pilot study designed to demonstrate the acceptability of onco-sexology management for laryngectomy patients and their partners in order to improve their perception of their intimate life. This is a non-interventional study (category 3 Loi Jardé), which will not result in any change in patient management. All procedures will be carried out in accordance with standard practice. Patients will be followed for 14 months.

Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Institut Claudius RegaudUpdated: Jun 16, 2026Locations: 1
Eligibility criteria

Patient to be treated for ORL cancer by total (pharyngo)laryngectomy [+5]

Patient with another co-existing malignant disease at the time of inclusion. [+2]

Status: Recruiting

Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems. The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy. Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.

Participants needed: 105
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Institut Claudius RegaudUpdated: Jul 31, 2025Locations: 1
Eligibility criteria

Age ≥ 18 years at study entry. [+4]

Pregnant or lactating women. [+2]